| Literature DB >> 33712933 |
J D Hodgkinson1,2, G Worley3,4, J Warusavitarne3,4, G B Hanna4, C J Vaizey3,4, O D Faiz3,4.
Abstract
PURPOSE: The Ventral Hernia Working Group (VHWG) classification of ventral/incisional hernia (IH) was developed by expert consensus in 2010. Subsequently, Kanters et al. have demonstrated the validity of a modified version of the system for predicting short-term outcomes. This study aims to evaluate the modified system for predicting hernia recurrence.Entities:
Keywords: Incisional hernia; Recurrent hernia; VHWG classification; Ventral hernia
Mesh:
Year: 2021 PMID: 33712933 PMCID: PMC8370963 DOI: 10.1007/s10029-021-02379-8
Source DB: PubMed Journal: Hernia ISSN: 1248-9204 Impact factor: 4.739
Fig. 1An overview of the Ventral Hernia Working Group (VHWG) Classification and the Kanters modified-VHWG classification
OPCS codes used to identify incisional/ventral hernia surgery in the HES database and ICD-10 and OPCS codes used to group patients according to the Ventral Hernia Working Group classification
| Hernia procedure OPCS code | Comorbidity ICD-10 code | Concomitant GI tract surgery OPCS code |
|---|---|---|
T25—primary repair of incisional hernia T26—repair of recurrent incisional hernia T27—primary repair of ventral hernia T28—abdominal wall reconstruction Y71.2—modifier for recurrent hernia | E10-14—diabetes mellitus J44—chronic obstructive pulmonary disease D80-84—immunodeficiency Y434—immunosuppressive medication K50-51—inflammatory bowel disease I25—chronic ischaemic heart disease I50—heart failure Q796—hypermobility/Ehlers–Danlos syndrome | G01–11, 26–29, 30–36, 40–41, 49, 50–53, 60–61, 63, 68–69, 70–79—small bowel operation H01–19, 29, 32–33—colon operation J19, 27.1–3, 29.1–2, 30.1–3, 34–36, 54.1, 56.1–3, 56.8–9—other GI tract operation |
Baseline demographics of the whole cohort split by modified-VHWG grade
| Modified VHWG grade | Whole cohort | |||
|---|---|---|---|---|
| 1 | 2 | 3 | Total | |
| Sex (male) | 81,271 (47.3) | 9,905 (46.4) | 10,257 (49.0) | 101,433 (47.4) |
| Age (mean ± SD) | 54.63 (15.8) | 64.05 (12.2) | 64.98 (14.7) | 56.59 (15.9) |
| 18–29 | 9,759 (5.7) | 120 (0.6) | 402 (1.9) | 10,281 (4.8) |
| 30–39 | 23,731 (13.8) | 592 (2.8) | 957 (4.6) | 25,280 (11.8) |
| 40–49 | 33,729 (19.6) | 2,095 (9.8) | 4,982 (9.5) | 37,806 (17.7) |
| 50–59 | 35,122 (20.4) | 4,063 (19.0) | 3,226 (15.4) | 42,411 (19.8) |
| 60–69 | 34,786 (20.2) | 6,791 (31.8) | 5,221 (24.9) | 46,798 (21.9) |
| 70–79 | 26,000 (15.1) | 5,865 (27.5) | 5,945 (28.4) | 37,810 (17.7) |
| > 80 | 8,656 (5.0) | 1,820 (8.5) | 3,220 (15.4) | 13,696 (6.4) |
| Hernia comorbidity | N/A | 21,346 (100) | 4,102 (19.6) | 25,448 (11.9) |
| Diabetes | N/A | 14,779 (69.2) | 2,604 (12.4) | 17,383 (8.1) |
| COPD | N/A | 7,676 (36.0) | 1,747 (8.3) | 9,423 (4.4) |
| Immuno-deficiency | N/A | 88 (0.4) | 18 (0.0) | 106 (0.0) |
| IHD | 5,553 (3.2) | 2,658 (12.5) | 1,741 (8.3) | 9,952 (4.6) |
| Pre-existing IBD | 1,674 (1.0) | 247 (1.2) | 1,484 (7.1) | 3,405 (1.6) |
| Crohn’s Disease | 1,152 (0.7) | 137 (0.6) | 870 (4.2) | 2,159 (1.0) |
| UC | 522 (0.3) | 110 (0.5) | 614 (2.9) | 1,246 (0.6) |
| Ehlers–Danlos | 20 (0.0) | 1 (0.0) | 3 (0.0) | 24 (0.0) |
| Contaminated hernia repair | N/A | N/A | 20,953 (100) | 20,953 (9.8) |
| Emergency operation | 21,305 (12.4) | 4,337 (20.3) | 8,814 (42.1) | 34,456 (16.1) |
| Planned as day case | 53,695 (31.3) | 3,053 (14.3) | 463 (2.2) | 57,211 (26.7) |
VHWG Ventral Hernia Working Group, IHD ischaemic heart disease, IBD inflammatory bowel disease, UC ulcerative colitis
Fig. 2Point prevalence of incisional hernia (IH) surgery (blue) per 100,000 of the population and of contaminated hernia surgery per 100 hernia surgeries (red)
Outcomes from index hernia operation
| VHWG grade | Total ( | |||
|---|---|---|---|---|
| 1 ( | 2 ( | 3 ( | ||
| LOS (days) | 2 | 3 | 11 | 2 |
| (Median; IQR; range) | (0–4; 0–564) | (1–7; 0–378) | (6–20; 0–792) | (1–6; 0–792) |
| 30-day mortality | 1,012 (0.6) | 391 (1.8) | 1,538 (7.3) | 2,941 (1.4) |
| 90-day mortality | 1,703 (1.0) | 625 (2.9) | 2,222 (10.6) | 4,550 (2.1) |
| Recurrent hernia surgery | 13,889 (8.1) | 1,566 (7.3) | 2,259 (10.7) | 17,714 (8.3) |
| Multiple hernia recurrences | 2,412 (17.4) | 260 (16.6) | 468 (20.7) | 3,140 (17.7) |
Multiple hernia recurrences are presented as a proportion of the total hernia recurrences
LOS length of stay
Unadjusted and adjusted proportionate hazard cox regression model evaluating factors linked to further hernia surgery
| Unadjusted analysis | Adjusted multi-variate analysis | |||
|---|---|---|---|---|
| Hazard ratio (95% CI) | Hazard ratio (95% CI) | |||
| Age | 1.002 (1.001–1.003) | < 0.0001 | 0.997 (0.994–1.001) | 0.45 |
| Sex (male) | 1.03 (0.99–1.08) | 0.14 | ||
| Hernia comorbidity | 1.09 (1.02–1.17) | 0.01 | 1.05 (1.00–1.10) | 0.05 |
| IHD | 1.17 (1.06–1.30) | 0.003 | 1.05 (0.98–1.10) | 0.18 |
| IBD | 1.76 (1.55–2.01) | < 0.0001 | 1.52 (1.38–1.67) | < 0.0001 |
| Hypermobility | 2.53 (0.95–6.74) | 0.06 | ||
| Contamination | 1.78 (1.67–1.89) | < 0.0001 | 1.69 (1.62–1.77) | < 0.0001 |
| Emergency surgery | 1.03 (0.97–1.09) | 0.29 | ||
IHD ischaemic heart disease, IBD inflammatory bowel disease
Cox regression analysis of the St Mark’s modified Ventral Hernia Working Group (VHWG) grading system for its ability to discriminate between patients risk of further hernia surgery
| St Mark’s modified VHWG grade | Patient number ( | Further hernia surgery ( | Patient years of follow-up | Recurrences/patient year of follow-up | Hazard ratio (95% CI) | |
|---|---|---|---|---|---|---|
| 1 | 170,109 (79.5) | 13,661 (8.0) | 918,713 | 0.015 | 1 | |
| 2 | 23,020 (10.8) | 1,794 (7.8) | 83,232 | 0.022 | 1.19 (1.13–1.25) | < 0.0001 |
| 3 | 20,953 (9.8) | 2259 (10.8) | 72,799 | 0.031 | 1.79 (1.72–1.88) | < 0.0001 |
Fig. 3Survival curve demonstrating the ability of the St Mark’s modified Ventral Hernia Working Group (VHWG) grading system to discriminate between the risk of further hernia surgery
Fig. 4Receiver-operating characteristic curve assessing the validity of the St Mark’s modified Ventral Hernia Working Group (VHWG) grading system (AUC 0.73; 95% CI 0.728–0.736)